MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $3,930,000 | – | 111,108 | – | 1.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |